With the help of a femur fracture lawyer, a Pennsylvania woman last month filed a lawsuit in New Jersey District court alleging that a generic version of the osteoporosis drug Fosamax caused her to suffer a thigh bone fracture.
According to the complaint filed in the U.S. District Court of New Jersey, Metz had been taking generic Fosamax manufactured by Merck Sharp & Dohme for approximately one year when her femur fractured as she was walking down a sidewalk. As a result of her injuries, two titanium rods were inserted into Metz's femur. You can click http://www.taxoterehairlawsuit.com/taxotere-hair-loss-lawsuit.aspx to get more info about hair loss lawsuit.
Additionally, complications arose during her surgery that required a stay in the intensive care unit (ICU) and a blood transfusion. Afterward, she underwent physical therapy and to this day still requires a cane to walk. Metz is seeking both compensatory and punitive damages in the product liability suit against Merck. She alleges that the pharmaceutical manufacturer designed a defective product and failed to warn of the drug's health risks.
Fosamax (alendronate sodium) belongs to a class of drugs known as bisphosphonates that have been increasingly associated with abnormal femur fractures, so-called because the thigh bone can break due to falls from a standing height or less. In February a study appearing in the Journal of the American Medical Association (JAMA) found that women aged 68 years and older who have been taking Fosamax for an extended period are at significantly higher risk of suffering an atypical femur fracture.